Subscriptions

Advertising

Resources

About Us

Contact Us

Create An Account Forgot Your Password?
Trouble logging in or creating an account? click here
Home This Month E-Weekly Newsletter Building a Facility Article Archive Second Opinions
Search:
Benchmarking
General Surgery
Accrediting/Quality
Anesthesia
Code/Bill/Reimburse
Building/Renovating
/_media/adv/web/images/2010/20100407_ORX_LB-01_154x100.gif
/_media/adv/web/images/2010/20100511_Arthrex_LB_154x100.gif
/_media/adv/web/images/2010/20100824_HCA_LB_154x100.gif
Outpatient Surgery E-Weekly

OR Excellence Pre-Registration Ends Wednesday

This Wednesday, Sept. 1, is your last chance to participate in Outpatient Surgery Magazine's OR Excellence 2010 Pre-Registration Contest. There's no...

Researchers Predict Anesthesiologist Shortage, CRNA Surplus

A recent analysis of the anesthesia labor market speculates that a current shortfall of providers across the surgical industry could widen in the ne...

A Change of Mind: Anesthesia, Consciousness and the Brain

The brain works through different processes as it transitions between conscious and unconscious states, a finding that bucks commonly held assumptio...

Home > News > February, 2010

FDA Extends Timeline for SS1 Replacement by 18 Months

Facilities have until August 2011 to transition to alternative reprocessors.

The FDA is giving healthcare facilities 18 more months to discontinue use of the Steris System 1 tabletop liquid chemical reprocessor and transition to a legally marketed alternative device.

In an update notice, the agency says it extended the recommended time period for replacing the SS1 after healthcare providers and professional organizations warned that the original 3- to 6-month transition period would be difficult for facilities to attain and therefore could "adversely affect patient care."

Facilities that fail to meet the 18-month deadline won't be penalized, but the FDA urges you to transition to FDA-cleared alternative reprocessing devices as soon as possible. "The current SS1 is a misbranded and adulterated medical device because it has not been cleared by FDA as safe and effective for its labeled claims," the agency warns.

Irene Tsikitas

Categories: Gastroenterology, Infection Control, Product Reports, News
Already have an account? Please sign in:
Email Address:
Password:
PRODUCT & SERVICE RESOURCES
Product & Service Showcase
A showcase of products and services geared to make your facility better.
Professional Services Platinum Pages
A guide of people and companies to help make your facility better.
Other Articles That May Interest You
Experts Reassure Public About Safety of Propofol in Surgery
Michael Jackson’s death puts the spotlight on commonly used anesthetic.
Poor Communication Linked to Wrong-site, Wrong-procedure Errors
Researchers say surgical professionals need to talk sooner and more effectively to avoid adverse events.
Best Practices
Decrease Your Colonoscopy Procedure Times